Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 4.365
+0.015 (0.34%)
Jul 24, 2026, 4:50 PM CET
Genomtec Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.04 | 4.03 | 2.32 | 1.15 | 0.49 | 0.22 | |
Revenue Growth (YoY) | 292.64% | 73.80% | 102.53% | 135.80% | 124.37% | 964.59% |
Cost of Revenue | - | - | - | 0 | 0.03 | 0.06 |
Gross Profit | 5.04 | 4.03 | 2.32 | 1.15 | 0.46 | 0.16 |
Selling, General & Admin | 5.59 | 6.47 | 9.14 | 9.43 | 8.57 | 6.62 |
Depreciation & Amortization Expenses | - | - | - | - | - | 0.32 |
Research & Development | 8.13 | 7.2 | 4.31 | 0.79 | 3.24 | - |
Other Operating Expenses | - | -0.09 | -0.08 | 0.07 | 0.16 | 0.81 |
Total Operating Expenses | 13.71 | 13.58 | 13.38 | 10.29 | 11.96 | 7.75 |
Operating Income | -8.68 | -9.55 | -11.06 | -9.15 | -11.51 | -7.59 |
Interest Income | 0.01 | 0.08 | 0.07 | 0.06 | - | - |
Interest Expense | -0.06 | -0.81 | -0.21 | -0.37 | -0.39 | -0.13 |
Other Non-Operating Income (Expense) | - | - | - | - | - | 0.34 |
Total Non-Operating Income (Expense) | -0.05 | -0.73 | -0.13 | -0.3 | -0.39 | 0.21 |
Pretax Income | -9.29 | -10.27 | -11.19 | -9.03 | -11.88 | -5.75 |
Provision for Income Taxes | 0.01 | -0.05 | 0.02 | -0.02 | 0.05 | -0.48 |
Net Income | -17.33 | -10.22 | -11.21 | -18.03 | -23.86 | -5.27 |
Net Income to Common | -17.33 | -10.22 | -11.21 | -18.03 | -23.86 | -5.27 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 15 | 15 | 13 | 12 | 9 | 8 |
Shares Outstanding (Diluted) | 15 | 15 | 14 | 13 | 11 | 9 |
Shares Change (YoY) | 8.25% | 11.31% | 8.48% | 14.97% | 23.18% | 0.66% |
EPS (Basic) | -0.61 | -0.68 | -0.84 | -0.74 | -1.27 | -0.87 |
EPS (Diluted) | -0.61 | -0.68 | -0.84 | -0.74 | -1.27 | -0.87 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -9.28 | -10.77 | -6.66 | -4.43 | 0.74 | -5.29 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.61 | -0.71 | -0.49 | -0.35 | 0.07 | -0.60 |
Gross Margin | 100.00% | 100.00% | 100.00% | 99.91% | 93.62% | 73.53% |
Operating Margin | -172.19% | -236.61% | -476.30% | -798.08% | -2367.90% | -3504.22% |
Profit Margin | -344.01% | -253.40% | -482.89% | -1572.95% | -4908.64% | -2434.45% |
FCF Margin | -184.10% | -266.86% | -286.82% | -386.13% | 151.65% | -2440.86% |
EBITDA | -6.14 | -7.12 | -8.73 | -7.99 | -11.07 | -7.09 |
EBITDA Margin | -121.93% | -176.38% | -375.92% | -697.21% | -2278.19% | -3271.54% |
EBIT | -8.68 | -9.55 | -11.06 | -9.15 | -11.51 | -7.59 |
EBIT Margin | -172.19% | -236.61% | -476.30% | -798.08% | -2367.90% | -3504.22% |
Effective Tax Rate | -0.06% | 0.49% | -0.18% | 0.20% | -0.39% | 8.31% |